Description

Sodium (19E,21E,23E,25E,27E,29E,31E)-33-(4-amino-3,5-dihydroxy-6-methyl-oxan-2-yl)oxy-1,3,4,7,11,17,37-heptahydroxy-15,16,18-trimethyl-9,13-dioxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylate is a complex, high-purity sodium salt derivative of a polyene macrolide antibiotic structure. This compound is valued for its specific biological activity and is a critical advanced pharmaceutical intermediate in the synthesis of specialized therapeutic agents. It is primarily required by pharmaceutical R&D laboratories and manufacturers engaged in the production of novel anti-infective and antifungal medications.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of polyene macrolide antibiotics and related therapeutic compounds.
• Antifungal Agent Research: Used in the research and development of new antifungal medications targeting fungal cell membranes.
• Biochemical Research: Serves as a reference standard and active component in microbiological and pharmacological studies.
• Veterinary Medicine Development: Potential application in developing treatments for fungal infections in animals.
• API Synthesis: Intermediate in the multi-step synthesis of complex Active Pharmaceutical Ingredients (APIs) with polyene structures.

Basic Information

Item	Detail
Product Name	Sodium (19E,21E,23E,25E,27E,29E,31E)-33-(4-amino-3,5-dihydroxy-6-methyl-oxan-2-yl)oxy-1,3,4,7,11,17,37-heptahydroxy-15,16,18-trimethyl-9,13-dioxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylate
CAS No.	75442-91-0
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Sodium Salt of Partricin A; Partricin A Sodium Salt; Partricin Sodium; Antibiotic A-5283 Sodium Salt; (19E,21E,23E,25E,27E,29E,31E)-33-[(4-Amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy]-1,3,4,7,11,17,37-heptahydroxy-15,16,18-trimethyl-9,13-dioxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic Acid Sodium Salt
EINECS	Contact for details

Quality Control

Our sodium partricin derivative is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical intermediate use. Certificates of Analysis (COA) detailing specific batch results are provided and can be tailored to support regulatory filings for drug master files (DMF) or investigational new drug (IND) applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption and degradation. For long-term storage, consider desiccants or inert atmosphere packaging.

Specification

Item	Specification
Appearance	Yellow to brownish-yellow powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Residue on Ignition	Contact for details
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 5.0%
Microbial Limits	Absence of specified pathogens

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.